Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers

Prevalence and Heterogeneity of Cerebrovascular Disease Imaging Lesions

(2020) Jonathan Graff-Radford et al.   MAYO CLINIC PROCEEDINGS

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

(2019) Isabelle Bos et al.   Alzheimers & Dementia

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

(2019) Oskar Hansson et al.   Alzheimers Research & Therapy

White matter hyperintensities: relationship to amyloid and tau burden

(2019) Jonathan Graff-Radford et al.   BRAIN

Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia

(2019) Clifford R. Jack et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin

(2019) Michelle M. Mielke et al.   Alzheimers & Dementia

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

(2019) Sebastian Palmqvist et al.   EMBO Molecular Medicine

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

(2018) Erik Portelius et al.   ACTA NEUROPATHOLOGICA

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Neurofilament relates to white matter microstructure in older adults

(2018) Elizabeth E. Moore et al.   NEUROBIOLOGY OF AGING

A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation

(2018) Lorenzo Gaetani et al.   Alzheimers Research & Therapy

The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease

(2018) Hlin Kvartsberg et al.   ACTA NEUROPATHOLOGICA

Development of a cerebrovascular MRI biomarker for cognitive aging

(2018) Prashanthi Vemuri et al.   ANNALS OF NEUROLOGY

Statins and Brain Health: Alzheimer’s Disease and Cerebrovascular Disease Biomarkers in Older Adults

(2018) Vijay K. Ramanan et al.   JOURNAL OF ALZHEIMERS DISEASE

Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment

(2018) Silke Kern et al.   JAMA Neurology

Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis

(2018) Won Hwa Kim et al.   NeuroImage-Clinical

Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease

(2017) Joana B. Pereira et al.   NEUROBIOLOGY OF AGING

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

(2017) Niklas Mattsson et al.   JAMA Neurology

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

(2016) Niklas Mattsson et al.   EMBO Molecular Medicine

Increased CSF neurogranin concentration is specific to Alzheimer disease

(2016) Henrietta Wellington et al.   NEUROLOGY

Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease

(2016) Rawan Tarawneh et al.   JAMA Neurology

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

(2016) Henrik Zetterberg et al.   JAMA Neurology

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

(2016) Shorena Janelidze et al.   Annals of Clinical and Translational Neurology

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease

(2015) Erik Portelius et al.   BRAIN

Data Resource Profile: The Rochester Epidemiology Project (REP) medical records-linkage system

(2012) J. L. St Sauver et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Disruption of limbic white matter pathways in mild cognitive impairment and Alzheimer's disease: A DTI/FDG-PET Study

(2011) Andrea C. Bozoki et al.   HUMAN BRAIN MAPPING

Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: Application to normal elderly and Alzheimer's disease participants

(2009) Kenichi Oishi et al.   NEUROIMAGE

The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics

(2008) Rosebud O. Roberts et al.   NEUROEPIDEMIOLOGY